Extended-spectrum cephalosporinases: structure, detection and epidemiology. - Wikidata - awgldk - TriplyDB

Extended-spectrum cephalosporinases: structure, detection and epidemiology.

Extended-spectrum cephalosporinases: structure, detection and epidemiology.

http://www.wikidata.org/entity/Q36895772

about

Updated functional classification of beta-lactamases The use of cephalosporins for gonorrhea: the impending problem of resistance Structure of AmpC β-lactamase (AmpCD) from anEscherichia coliclinical isolate with a tripeptide deletion (Gly286-Ser287-Asp288) in the H10 helix Genetic and kinetic characterization of the novel AmpC β-lactamases DHA-6 and DHA-7.Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae.Pseudomonas aeruginosa: resistance to the max Extended-spectrum AmpC cephalosporinase in Acinetobacter baumannii: ADC-56 confers resistance to cefepime.Two novel CMY-2-type β-lactamases encountered in clinical Escherichia coli isolates Hydrolysis spectrum extension of CMY-2-like β-lactamases resulting from structural alteration in the Y-X-N loop.Genetic characterization of Pseudomonas aeruginosa-resistant isolates at the university teaching hospital in Iran Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance Characterization of the new AmpC β-lactamase FOX-8 reveals a single mutation, Phe313Leu, located in the R2 loop that affects ceftazidime hydrolysis.Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil.AmpC beta-lactamases.Acinetobacter: a potential reservoir and dispenser for β-lactamases.Emergence of ertapenem resistance in an Escherichia coli clinical isolate producing extended-spectrum beta-lactamase AmpC.Structural and mechanistic insights into the inhibition of class C β-lactamases through the adenylylation of the nucleophilic serine.Characterization of Beta-lactamases in Faecal Enterobacteriaceae Recovered from Healthy Humans in Spain: Focusing on AmpC Polymorphisms.Occurrence of ST23 complex phylogroup A Escherichia coli isolates producing extended-spectrum AmpC beta-lactamase in a French hospital.Increased Hydrolysis of Oximino-β-Lactams by CMY-107, a Tyr199Cys Mutant Form of CMY-2 Produced by Escherichia coli.Activity of temocillin, mecillinam, ceftazidime, and ceftazidime/avibactam against carbapenem-non-susceptible Enterobacteriaceae without carbapenemase production.Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC.Emergence of Escherichia coli producing extended-spectrum AmpC β-lactamases (ESAC) in animals Gentamicin in bone cement: A potentially more effective prophylactic measure of infectionin joint arthroplasty Genetic and functional variability of AmpC-type β-lactamases from Acinetobacter baumannii.Extended-spectrum cephalosporinase in Acinetobacter baumannii.Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.Extended-spectrum cephalosporinases in Pseudomonas aeruginosa.Role of the Ser-287-Asn replacement in the hydrolysis spectrum extension of AmpC beta-lactamases in Escherichia coli.Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa.New mutations in ADC-type β-lactamases from Acinetobacter spp. affect cefoxitin and ceftazidime hydrolysis.Activity of avibactam against Enterobacter cloacae producing an extended-spectrum class C β-lactamase enzyme.

P2860

Q24644798-D78D4629-5803-4864-8C00-C993185E561E Q24656750-940C9CB0-9501-440D-83CF-0C0409A18F81 Q27655673-ED1D1CF0-6D56-4065-AB43-5E00DE2F0024 Q30365832-A32C1BAE-622B-4C84-A7E5-B696541276CF Q33816207-D458F47F-0125-4369-8D7C-66C1C002C03B Q35084559-7D495ACE-E527-471A-B0DE-8CC3B4407E01 Q35270789-7C103CCF-9B1A-40A9-9E01-C43BF8C24EA1 Q35440638-3B462511-67AB-499E-9E36-0F0CFBBAA2E4 Q35806387-B4A6B524-7F71-4C80-9111-1243E1F8B099 Q35999585-510C6AE6-189B-445A-A320-16A7535D7C47 Q36076066-D431C4AB-26C4-484A-9B25-63798392F5B3 Q37263714-DF50FE62-6032-41AE-9BC0-35DFF2BE0688 Q37333114-585C941F-F017-4678-A803-34CB83AF17F4 Q37366249-C10A14BC-FDC1-47B1-84DE-79B668675A57 Q37946953-A131578C-4F77-4511-B500-9A7947240575 Q38282628-635A8589-586B-4725-B044-2C2F204C9CDE Q38407413-BB38DDED-6C7A-4B60-BDEB-A144D2DDFC6E Q39077119-30724E43-24B5-49B4-8DBD-B9A557CB8C13 Q40334842-A768B72E-46EE-4224-A91C-28F24A50CE86 Q40965338-C755D10D-7F1C-4B13-A6A8-64DA2A9807EA Q40967518-F0270B12-8F39-487A-94A6-DD439F554090 Q41508049-139AD51F-C2C4-4276-A6E8-8B1371439B52 Q41766424-A27B28D2-73EB-4F57-B986-39E108A33B8D Q42266607-24D6D79B-B6B2-4270-8954-F1E5934216E8 Q42376054-E6B0EB5A-291A-4F2D-9483-28943D887ABA Q42576942-E8583BDA-63AE-497D-9CB2-6D72732C9B60 Q42577662-08DFA3F5-9B94-44A1-8F84-72547E6CE29F Q42612014-2F344964-6904-4409-820F-529BA09668D0 Q43128351-9C2A384E-F76F-4DFB-ABC6-0A5579D61045 Q43215482-D735C72F-35ED-404B-8F93-EB88F7AA32A0 Q49921578-C470611C-4E07-4B64-A29C-5040198E616B Q54288863-5F20DAB4-900A-4B53-84D1-CAB426ADBE7C Q54571557-D3CC337F-C9F7-4DEF-9342-FB6672AF7E2D

P2860

Extended-spectrum cephalosporinases: structure, detection and epidemiology.

http://www.wikidata.org/entity/Q36895772

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Extended-spectrum cephalosporinases: structure, detection and epidemiology.

@en

type

label

Extended-spectrum cephalosporinases: structure, detection and epidemiology.

@en

prefLabel

Extended-spectrum cephalosporinases: structure, detection and epidemiology.

@en

P1433

Q36895772-886F9B25-30BE-4E2C-AADA-072F430E0D0F

P1476

Q36895772-24FB2777-B20C-4814-B39C-8E26DCA3705C

P2093

Q36895772-23775DC4-2C0E-4D34-9360-D542E2948B34

P2860

Q36895772-05109653-BFB3-4AFF-AF22-32628742723C

Q36895772-1188672E-82F7-4D1D-B95F-7344F84C0DEF

Q36895772-1420833D-F51D-474D-9B3D-472C92B8EE55

Q36895772-19B3DAA0-F1FB-4BFD-A3EC-E61A0A8A0818

Q36895772-2E8F067D-DC9A-47D6-80B7-F1EB14B00A86

Q36895772-31D0645F-DE26-437B-B9C5-F01A8E20910A

Q36895772-3799B83C-D402-4654-B7AC-6579127CB61B

Q36895772-3F9D83B3-F217-4E20-B2F2-FF07372047A2

Q36895772-3FC82F94-6637-4570-8DE0-DDDCE8A587C9

Q36895772-455463A3-E9D6-4A84-9D0B-5CC1D0AF23A0

P304

Q36895772-91A597EE-3F81-45D0-8F32-04BAC505B14B

P31

Q36895772-B3737A18-1696-4B1B-B1F7-5B53251899C8

P356

Q36895772-403E1A3B-15C4-4D83-AC2C-3F48AD44C8DA

P433

Q36895772-64170FE7-0843-44EB-B575-022CDBBFA5C0

P478

Q36895772-90512CD5-84EE-4751-B64A-EF8EDA5D789C

P50

Q36895772-B8E702E3-E96B-430D-BF78-0973BE0F65BB

P577

Q36895772-E3450634-B6FD-4F71-B6FC-ED309266D377

P698

Q36895772-6E0E3A43-8879-4789-B041-9832DFDCA2EA

P356

17460913.2.3.297

P1433

Future Microbiology

P1476

Extended-spectrum cephalosporinases: structure, detection and epidemiology.

@en

P2093

Hedi Mammeri

http://www.w3.org/2001/XMLSchema#string

P2860

Plasmid-determined AmpC-type beta-lactamases.

Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion

Structures of ceftazidime and its transition-state analogue in complex with AmpC beta-lactamase: implications for resistance mutations and inhibitor design

Structure-based approach for binding site identification on AmpC beta-lactamase

Structural basis for imipenem inhibition of class C beta-lactamases.

Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: possible implications for the oxyanion hypothesis and for inhibitor design

Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.

Rapid and simple determination of the Escherichia coli phylogenetic group.

Dissemination of transferable AmpC-type beta-lactamase (CMY-10) in a Korean hospital.

Horizontal transfer of blaCMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19.

P304

297-307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/17460913.2.3.297

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Patrice Nordmann

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17661704

http://www.w3.org/2001/XMLSchema#string